21958864|t|The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration.
21958864|a|S100B, a glial-secreted protein, is believed to play a major role in neurodegeneration in Alzheimer's disease, Down syndrome, traumatic brain injury, and spinocerebellar ataxia type 1 (SCA1). SCA1 is a trinucleotide repeat disorder in which the expanded polyglutamine mutation in the protein ataxin-1 primarily targets Purkinje cells of the cerebellum. Currently, the exact mechanism of S100B-mediated Purkinje cell damage in SCA1 is not clear. However, here we show that S100B may act via the activation of the receptor for advanced glycation end product (RAGE) signaling pathway, resulting in oxidative stress-mediated injury to mutant ataxin-1-expressing neurons. To combat S100B-mediated neurodegeneration, we have designed a selective thermally responsive S100B inhibitory peptide, Synb1-ELP-TRTK. Our therapeutic polypeptide was developed using three key elements: (1) the elastin-like polypeptide (ELP), a thermally responsive polypeptide, (2) the TRTK12 peptide, a known S100B inhibitory peptide, and (3) a cell-penetrating peptide, Synb1, to enhance intracellular delivery. Binding studies revealed that our peptide, Synb1-ELP-TRTK, interacts with its molecular target S100B and maintains a high S100B binding affinity as comparable with the TRTK12 peptide alone. In addition, in vitro studies revealed that Synb1-ELP-TRTK treatment reduces S100B uptake in SHSY5Y cells. Furthermore, the Synb1-ELP-TRTK peptide decreased S100B-induced oxidative damage to mutant ataxin-1-expressing neurons. To test the delivery capabilities of ELP-based therapeutic peptides to the cerebellum, we treated mice with fluorescently labeled Synb1-ELP and observed that thermal targeting enhanced peptide delivery to the cerebellum. Here, we have laid the framework for thermal-based therapeutic targeting to regions of the brain, particularly the cerebellum. Overall, our data suggest that thermal targeting of ELP-based therapeutic peptides to the cerebellum is a novel treatment strategy for cerebellar neurodegenerative disorders.
21958864	69	74	S100B	Gene	20203
21958864	84	101	neurodegeneration	Disease	MESH:D019636
21958864	103	108	S100B	Gene	6285
21958864	172	189	neurodegeneration	Disease	MESH:D019636
21958864	193	212	Alzheimer's disease	Disease	MESH:D000544
21958864	214	227	Down syndrome	Disease	MESH:D004314
21958864	229	251	traumatic brain injury	Disease	MESH:D000070642
21958864	257	286	spinocerebellar ataxia type 1	Disease	MESH:D020754
21958864	288	292	SCA1	Disease	MESH:D020754
21958864	295	299	SCA1	Disease	MESH:D020754
21958864	305	334	trinucleotide repeat disorder	Disease	MESH:D030342
21958864	357	370	polyglutamine	Disease	MESH:D030342
21958864	395	403	ataxin-1	Gene	20238
21958864	490	495	S100B	Gene	20203
21958864	505	525	Purkinje cell damage	Disease	MESH:D002280
21958864	529	533	SCA1	Disease	MESH:D020754
21958864	575	580	S100B	Gene	20203
21958864	615	658	receptor for advanced glycation end product	Gene	11596
21958864	660	664	RAGE	Gene	11596
21958864	741	749	ataxin-1	Gene	20238
21958864	780	785	S100B	Gene	20203
21958864	795	812	neurodegeneration	Disease	MESH:D019636
21958864	864	869	S100B	Gene	20203
21958864	896	899	ELP	Gene	13168
21958864	982	1006	elastin-like polypeptide	Gene	13168
21958864	1008	1011	ELP	Gene	13168
21958864	1058	1064	TRTK12	Chemical	-
21958864	1082	1087	S100B	Gene	20203
21958864	1235	1238	ELP	Gene	13168
21958864	1281	1286	S100B	Gene	20203
21958864	1308	1313	S100B	Gene	6285
21958864	1426	1429	ELP	Gene	13168
21958864	1453	1458	S100B	Gene	6285
21958864	1469	1475	SHSY5Y	CellLine	CVCL:0019
21958864	1506	1509	ELP	Gene	13168
21958864	1533	1538	S100B	Gene	20203
21958864	1574	1582	ataxin-1	Gene	20238
21958864	1640	1643	ELP	Gene	13168
21958864	1701	1705	mice	Species	10090
21958864	1739	1742	ELP	Gene	13168
21958864	2003	2006	ELP	Gene	13168
21958864	2086	2124	cerebellar neurodegenerative disorders	Disease	MESH:D019636
21958864	Association	MESH:D020754	20203
21958864	Association	MESH:D019636	20203
21958864	Association	MESH:D004314	6285
21958864	Negative_Correlation	13168	6285
21958864	Association	MESH:D000070642	6285
21958864	Association	MESH:D030342	20238
21958864	Negative_Correlation	13168	20203
21958864	Positive_Correlation	11596	20203
21958864	Association	MESH:D020754	6285
21958864	Association	MESH:D002280	20203
21958864	Association	MESH:D000544	6285
21958864	Association	20203	20238
21958864	Association	MESH:D019636	6285
21958864	Association	MESH:D020754	20238

